Cortellis
Depends
Confidence: Medium
Buy only if you are a pharma or biotech org whose R&D, regulatory, or BD teams need deep drug, deal, and regulatory data and can absorb a six-figure annual contract.
New check
Comparison
Cortellis and DrugPatentWatch both land on Depends.
Buy only if you are a pharma or biotech org whose R&D, regulatory, or BD teams need deep drug, deal, and regulatory data and can absorb a six-figure annual contract.
Buy only if you run portfolio, BD, or litigation strategy inside a pharma company and need patent-cliff forecasting; the free trial makes testing cheap.
| Compare | ||
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Pharma competitive intelligence and BD teams | Pharma portfolio and lifecycle strategy teams |
| Who it's not for | Startups and small biotechs without six-figure data budgets | Hospitals, clinics, pharmacies . clinical needs, not market intelligence |
| Privacy | Backed by Clarivate's trust center, but a SAML vulnerability is referenced in reviews and itself has no security page.⁹ | No known public vulnerabilities found in the sources reviewed.14 |
| Support quality | No support-quality evidence found | No support evidence in sources |
| Public sentiment | Reddit users rate Cortellis data best-in-class among pharma intel databases but repeatedly gripe about the price.⁴ | No independent user reviews surfaced in the sources reviewed; coverage is vendor-authored content and trade news. |
| Biggest gotcha | Quote-based pricing with no list price; expect lengthy procurement and negotiation⁵ | Expect an enterprise-style sales process; published pricing is absent, so budget negotiation time.13 |